Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive cancers with extremely poor prognosis. Radiomics has shown prognostic ability in multiple types of cancer including PDAC. However, the prognostic value of traditional radiomics pipelines, which are based on hand-crafted radiomic features alone, is limited due to high correlation among features and the multiple testing problem. Deep learning architectures, such as Convolutional Neural networks (CNNs) have been shown to outperform traditional feature-based approaches in computer vision tasks such as object detection. Nonetheless, they require large sample sizes for training which limits their application in medical imaging. As an alternative solution, CNN-based transfer lea...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosi...
BACKGROUND: Non-small-cell lung cancer (NSCLC) patients often demonstrate varying clinical courses a...
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive cancers with extremely poor pr...
Abstract Background Cox proportional hazard model (CPH) is commonly used in clinical research for s...
Abstract Background Cox proportional hazard model (CPH) is commonly used in clinical research for s...
As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized me...
Abstract Objective This study aims to compare the feasibility and effectiveness of automatic deep le...
PurposeWe designed to construct one 3D VOI-based deep learning radiomics strategy for identifying ly...
As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized me...
As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized me...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
Almost every clinical specialty will use artificial intelligence in the future. The first area of pr...
Cho et al. use a radiomics-guided deep-learning approach to model the prognosis of lung adenocarcino...
Pancreatic ductal adenocarcinoma (PDAC) mortality rates are projected to rise by 2030 due to factors...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosi...
BACKGROUND: Non-small-cell lung cancer (NSCLC) patients often demonstrate varying clinical courses a...
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the most aggressive cancers with extremely poor pr...
Abstract Background Cox proportional hazard model (CPH) is commonly used in clinical research for s...
Abstract Background Cox proportional hazard model (CPH) is commonly used in clinical research for s...
As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized me...
Abstract Objective This study aims to compare the feasibility and effectiveness of automatic deep le...
PurposeWe designed to construct one 3D VOI-based deep learning radiomics strategy for identifying ly...
As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized me...
As the most lethal major cancer, pancreatic cancer is a global healthcare challenge. Personalized me...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
Almost every clinical specialty will use artificial intelligence in the future. The first area of pr...
Cho et al. use a radiomics-guided deep-learning approach to model the prognosis of lung adenocarcino...
Pancreatic ductal adenocarcinoma (PDAC) mortality rates are projected to rise by 2030 due to factors...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
IntroductionPancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosi...
BACKGROUND: Non-small-cell lung cancer (NSCLC) patients often demonstrate varying clinical courses a...